ArticleHaematologica2025
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Abstract read
In one paragraph
Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Cilia R PothastDepartment of Hematology, Leiden UMC, Leiden.
Quincy HofsinkDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam.
Sabine HaggenburgDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam.
Romy C DijklandDepartment of Hematology, Leiden UMC, Leiden.
Marian Van de MeentDepartment of Hematology, Leiden UMC, Leiden.
Kayleigh Van DijkDepartment of Hematology, Leiden UMC, Leiden.
Michel S BhoekhanDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam.
Nienke J E HaverkateAmsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam.
Johan Van MeerlooDepartment of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam.
J H Frederik FalkenburgDepartment of Hematology, Leiden UMC, Leiden.
Ruben A L De GroenDepartment of Hematology, Leiden UMC, Leiden.
Annoek E C BroersDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Jaap A Van DoesumDepartment of Hematology, University Medical Center Groningen, University of Groningen, Groningen.
Rob S Van BinnendijkCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, the Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboudumc, Nijmegen.
Gerco Den HartogCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven.
Birgit I Lissenberg-WitteDepartment of Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit, Amsterdam.
Arnon P KaterDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam.
Gaby P SmitsCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven.
Dorine WoutersDepartment of Laboratory Medicine, Central Diagnostic Laboratory, Amsterdam UMC, Amsterdam.
Ester M M Van LeeuwenAmsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Department of Laboratory Medicine, Laboratory for Specialized Diagnostics and Research, Laboratory Medical Immunology, Amsterdam UMC, Amsterdam.
Hetty J BontkesAmsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Department of Laboratory Medicine, Laboratory for Specialized Diagnostics and Research, Laboratory Medical Immunology, Amsterdam UMC, Amsterdam.
Neeltje A KootstraAmsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam.
Sandra Vogels-NooijenNetherlands Comprehensive Cancer Organisation, Utrecht.
Debbie Van BaarleDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen.
Rory D De VriesDepartment of Viroscience, Erasmus University Medical Center, Rotterdam.
Tom Van MeertenDepartment of Hematology, University Medical Center Groningen, University of Groningen, Groningen.
Pim G N J MutsaersDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam.
Abraham GoorhuisDepartment of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam.
Inger S NijhofDepartment of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Internal Medicine-Hematology, St. Antonius Hospital, Nieuwegein.
Mette D HazenbergDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Hematopoiesis, Sanquin Research, Amsterdam.
Mirjam H M HeemskerkDepartment of Hematology, Leiden UMC, Leiden.
Caroline E RuttenDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam. c.e.rutten@amsterdamumc.nl.
Cobra Kai Study TeamIris Kant, Thecla Graas, Belle Toussaint, Sterre de Jong, Shahan Darwesh, Sandjiv Mahes, Dora Kamminga, Matthijs Koelewijn, Gino Faber, Guus Beaumont, Marije Engel, R. Cheyenne Pierie, Suzanne Janssen, Kazimierz Groen, Judith Burger, Joey Bouhuijs, Paul Baars, Marit van Gils, Edith van Dijkman, Jarom Heijmans, Yara Witte, Rogers Nahui Palomino, Said Omar, Sonja Zweegman, Caya van den Vegt, Ilonka Arends-Halbesma, Emma de Pater, Margriet Dijkstra, Nynke Rots, Esther Siteur-van Rijnstra, Dennis de Rooij, Rogier Sanders, Meliawati Poniman, Wouter Olijhoek, Jacqueline van Rijswijk, Tim Beaumont, Lusia Çetinel, Louis Schellekens, Yvonne den Hartogh, Jacqueline Cloos, Suzanne Weijers, Saïda Tonouh-Aajoud, Selime Avci, Elianne Roelandse-Koop, Willem Dik.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.